NFE2L2 and metabolic dysfunction-associated steatotic liver disease: In addition, our study is the first to demonstrate that naringin can prevent the progression of NAFLD by suppressing the NF-kB/TNF-α pathway and increasing the Nrf2/HO-1 pathway in the liver of fructose-induced NAFLD rats.